Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Epigral Limited

Epigral Limited (EPIGRAL.NS) Stock Overview

Explore Epigral Limited’s financial performance, market position, analyst ratings, and future outlook.

EPIGRAL.NS●NSE
Basic MaterialsChemicals
₹1240.90
₹38.20(3.18%)
Indian Market opens in 4h 40m

Epigral Limited (EPIGRAL.NS)

Meyka AI Score

Z

Key Financials

Market Cap53.5B
P/E Ratio19.75
EPS (TTM)$63.09
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$952.34
3 Months$783.99
1 Year Target$1718.59

EPIGRAL.NS Stock Analysis & Investment Overview (NSE)

Our AI-powered analysis of Epigral Limited (NSE: EPIGRAL.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Epigral Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EPIGRAL.NS on the NSE shows an RSI of 69.42, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1718.59 for the NSE listing.

Key metrics behind Epigral Limited's NSE-traded stock include a P/E ratio of 19.75 and a market capitalization of 53.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EPIGRAL.NS on the NSE.

Price Performance (NSE: EPIGRAL.NS)

1-Day Change
3.18%
5-Day Change
14.16%
1-Month Change
6.73%
3-Month Change
N/A
6-Month Change
33.93%
Year-to-Date (YTD) Change
1.70%
1-Year Change
-32.32%
3-Year Change
40.19%
5-Year Change
151.22%
All-Time (Max) Change
205.30%

Contact Information

https://epigral.com
91 79 2970 9600
Epigral Tower, Ahmedabad, GU, 380015

Company Facts

11,350 Employees
IPO DateAug 18, 2021
CountryIN
Actively Trading

Frequently Asked Questions